z-logo
Premium
Progression of a focal ischemic lesion in rat brain during treatment with a novel glycine/nmda antagonist: An in vivo three‐dimensional diffusion‐weighted MR microscopy study
Author(s) -
Qiu Hui,
Hedlund Laurence W.,
Gewalt Sally L.,
Benveniste Helene,
Bare Thomas M.,
Johnson G. Allan
Publication year - 1997
Publication title -
journal of magnetic resonance imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.563
H-Index - 160
eISSN - 1522-2586
pISSN - 1053-1807
DOI - 10.1002/jmri.1880070421
Subject(s) - stroke (engine) , medicine , in vivo , nmda receptor , antagonist , anesthesia , middle cerebral artery , occlusion , ischemia , cardiology , biology , mechanical engineering , receptor , microbiology and biotechnology , engineering
Stroke was induced in two groups of anesthetized rats by occlusion of the middle cerebral artery (MCA) and ipsilateral common carotid artery. Group 1 (control) received vehicle and group 2 received the glycine N‐methyl‐D‐aspartate (NMDA) antagonist ZD9379. Stroke volume was assessed by three‐dimensional diffusion‐weighted MR microscopy at 2.5 and 6 hours of MCA occlusion. At 2.5 hours, stroke volumes were identical in the two groups. At 6 hours, stroke volumes had increased by 15% in the control group; in contrast, the treated group showed a 40% reduced stroke volume. Conclusions from this in vivo study were as follows: ( a ) our technique allows more efficient and accurate measurement of stroke volume with an improvement in resolution over a previous method; ( b ) the ability to measure stroke volume at multiple time points shows volume change and assessment of time dependency of drug treatment; (c) at 6 hours, the glycine antagonist ZD9379 reduced stroke volume by 40%.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom